- Zhang, Baihao;
- Vogelzang, Alexis;
- Miyajima, Michio;
- Sugiura, Yuki;
- Wu, Yibo;
- Chamoto, Kenji;
- Nakano, Rei;
- Hatae, Ryusuke;
- Menzies, Rosemary;
- Sonomura, Kazuhiro;
- Hojo, Nozomi;
- Ogawa, Taisaku;
- Kobayashi, Wakana;
- Tsutsui, Yumi;
- Yamamoto, Sachiko;
- Maruya, Mikako;
- Narushima, Seiko;
- Suzuki, Keiichiro;
- Sugiya, Hiroshi;
- Murakami, Kosaku;
- Hashimoto, Motomu;
- Ueno, Hideki;
- Kobayashi, Takashi;
- Ito, Katsuhiro;
- Hirano, Tomoko;
- Shiroguchi, Katsuyuki;
- Matsuda, Fumihiko;
- Suematsu, Makoto;
- Honjo, Tasuku;
- Fagarasan, Sidonia
Small, soluble metabolites not only are essential intermediates in intracellular biochemical processes, but can also influence neighbouring cells when released into the extracellular milieu1-3. Here we identify the metabolite and neurotransmitter GABA as a candidate signalling molecule synthesized and secreted by activated B cells and plasma cells. We show that B cell-derived GABA promotes monocyte differentiation into anti-inflammatory macrophages that secrete interleukin-10 and inhibit CD8+ T cell killer function. In mice, B cell deficiency or B cell-specific inactivation of the GABA-generating enzyme GAD67 enhances anti-tumour responses. Our study reveals that, in addition to cytokines and membrane proteins, small metabolites derived from B-lineage cells have immunoregulatory functions, which may be pharmaceutical targets allowing fine-tuning of immune responses.